2023
DOI: 10.1158/2767-9764.23957775.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Table S3 from Clinical benefit of autologous stem cell transplantation for multiple myeloma patients achieving undetectable minimal residual disease after induction treatment

Abstract: <p>Univariate analyses of PFS and OS in 407 transplant-eligible myeloma patients</p>

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles